Physician profile
Taylor Cook
NPI 1144858838
$1,547.96
in general payments reported to CMS, 2019-2025
18 companies · $765 in 2025
The $765 reported for 2025 was more than what 93% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.50 · 2022: $118 · 2024: $604 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.57 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $290.57 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $287.17 | 2024-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $238.37 | 2024-2025 | Remodulin, Orenitram, Tyvaso |
| Merck Sharp & Dohme LLC | $122.45 | 2024-2025 | Zerbaxa, Winrevair |
| Regeneron Healthcare Solutions, INC. | $92.52 | 2024-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $76.05 | 2022 | |
| Pulmonx Corporation | $64.44 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Lilly USA, LLC | $57.07 | 2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $53.81 | 2021-2025 | Fasenra |
| Electromed, INC. | $52.05 | 2025 | Smartvest |
| Astellas Pharma US INC | $41.85 | 2022 | |
| Abiomed | $34.71 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.43 | 2025 | Ofev |
| Pfizer INC. | $29.75 | 2021 | |
| Amgen INC. | $24.87 | 2024 | Tavneos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $23.25 | 2024 | |
| Philips North America LLC | $13.94 | 2025 | Vest Therapy Und |
| E.R. Squibb & Sons, L.L.C. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.